2021 Hematology and Oncology Best Practices (9 Days)
COURSE HIGHLIGHTS
There are several unique features that set this course apart from the others:
- Expert Faculty- Our faculty, unmatched in experience and expertise, will present the latest scientific findings in Hematology and Oncology, and best practices in the advances in cancer prevention, diagnosis, treatment, and survivorship.
- Daily Board Review Sessions- Allows attendees to gauge their knowledge base and become familiar with board-type questions.
CME & MOC
Attending 2021 HEMONC is an excellent way to fulfill your continuing medical education requirements. 2021 HEMONC attendees can also earn MOC points by attending sessions, participating in the daily lunch review sessions, and completing the post-course Learner Assessment.
Target Audience
This course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as for Oncology Nurse Practitioners, Nurses, Physician Assistants, Pharmacists, Advanced Practice Providers, Allied Professionals and other Healthcare Providers desiring a comprehensive review of hematology and medical oncology standards of care.
Learning Objectives
At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:
Hematology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand red cell disorders
Hematologic Malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Identify strategies for taking the board examinations
Oncology
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Understand the principles of management of gynecologic and other genito-urinary malignancies
- Recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Recognize principles of new developments in biologic therapy of cancer
- Contend with complexity of HIV related malignancies
Course Agenda
Course Director: Robert S. Siegel, MD
Tentative Agenda is subject to change. All times listed in Eastern Daylight Time (EDT).
** Please visit our Sponsor Exhibitors during breaks, if you have not scheduled an appointment in advance. **
Thursday, August 12, 2021- Day 1: Hematology Session | ||
Time | Topic | Presenter |
07:00 – 08:00 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
08:00 – 08:10 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:10 – 09:10 | Biology of Hematopoiesis | Jerry L. Spivak, MD |
09:10 – 10:10 | Iron Deficiency and Overload | Victor Gordeuk, MD |
10:10 – 10:30 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:30 – 11:30 | Hemoglobinopathies | Victor Gordeuk, MD |
11:30 – 12:15 | Anemia of Chronic Illness | Vera Malkovska, MD |
12:15 – 12:45 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
12:45 – 14:30 | Lunch Review Session 1: | Moderator: Dr. R. Siegel |
14:30 – 15:00 | Porphyrias | Victor Gordeuk, MD |
15:00 – 15:45 | Megaloblastic and Sideroblastic Anemias | Vera Malkovska, MD |
15:45 – 16:30 | Hemolytic Anemia | Imad Tabbara, MD |
16:30 – 16:50 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
16:50 – 17:35 | Red Cell Enzymes, Membranes, and Metabolism | Imad Tabbara, MD |
17:35 – 18:20 | Sickling Disorders | Santosh Saraf, MD |
18:20 – 18:30 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
18:30 – 19:30 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Friday, August 13, 2021- Day 2: Hematology Session | ||
Time | Topic | Presenter |
07:00 – 08:00 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
08:00 – 08:10 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:10 – 08:45 | Mechanisms for Clotting | Nigel S. Key, MD |
08:45 – 09:30 | The Hemophilias | Nigel S. Key, MD |
09:30 – 10:15 | Von Willebrand’s Disease | Alice Ma, MD |
10:15 – 10:35 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:35 – 11:15 | Acquired Disorders of Coagulation | Alice MA, MD |
11:15 – 12:15 | Hypercoagulable States | Kenneth A. Bauer, MD |
12:15 – 12:45 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
12:45 – 14:15 | Lunch Review Session 2: | Moderator: Dr. R. Siegel |
14:15 – 15:00 | ITP and Drug-Induced Thrombocytopenia | Robert S. Siegel, MD |
15:00 – 16:00 | Qualitative Platelet Defects | A. Koneti Rao, MD |
16:00 – 16:20 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
16:20 – 17:05 | Oral Anticoagulants and Antithrombotic Therapy | B. Gail Macik, MD |
17:05 – 17:50 | Parenteral Antithrombotics and Thrombolytic Therapy | B. Gail Macik, MD |
17:50 – 18:00 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
18:00 – 19:00 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Saturday, August 14, 2021- Day 3: Hematology Session | ||
Time | Topic | Presenter |
07:00 – 08:00 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
08:00 – 08:10 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:10 – 09:05 | (Topic: tbc) | (Faculty: tbc) |
09:00 – 09:35 | (Topic: tbc) | (Faculty: tbc) |
09:35 – 10:20 | White Cell Disorders | Amy DeZern, MD |
10:20– 10:40 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:40 – 11:40 | Bone Marrow Failure | Amy DeZern, MD |
11:40 – 12:05 | Consumptive Thrombohemorrhagic Disorders (DIC, TTP, HUS) | Michele Lambert, MD |
12:05 – 12:35 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
12:35 – 14:05 | Lunch Review Session 3: | Moderator: Dr. R. Siegel |
14:05 – 15:05 | DIC, HIT, and Limb Gangrene | Theodore Warkentin, MD |
15:05 – 15:35 | Problems in Hemostasis & Thrombosis | Dr. Lambert | Dr. Siegel | |
15:35 – 15:55 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
15:55 – 16:40 | Hematologic Complications of Pregnancy | Robert S. Siegel, MD |
16:40 – 17:25 | ABO Incompatibility and Other Transfusion-Related Issues in Hematopoietic Transplantation | Shelley Kalsi, MD |
17:25 – 18:10 | Review of Cellular Morphology | Donald Karcher, MD |
18:10 – 18:15 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
18:15 – 19:30 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Sunday, August 15, 2021- Day 1: Hematologic Malignancies Session | ||
Time | Topic | Presenter |
06:30 – 07:30 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
07:30 – 07:40 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
07:40 – 08:40 | Pathology of Lymphomas | L. Jeffrey Medeiros, MD |
08:40 – 09:40 | Non-Hodgkin’s Lymphoma | John Leonard, MD |
09:40 – 10:00 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:00 – 11:00 | Multiple Myeloma, Plasmacytoma, and MGUS | S. Vincent Rajkumar, MD |
11:00 – 11:45 | Hodgkin’s Lymphoma | John Leonard, MD |
11:45 – 12:30 | Acute Lymphocytic Leukemia | Hagop Kantarjian, MD |
12:30 – 13:00 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
13:00 – 14:45 | Lunch Review Session 4: | Moderator: Dr. R. Siegel |
14:45 – 15:30 | Chronic Myeloid Leukemia | Hagop Kantarjian, MD |
15:30 – 16:15 | Chronic Lymphocytic Leukemia | Matthew Davids, MD |
16:15 – 16:35 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
16:35 – 17:20 | Myelodysplasia | Mikkael Sekeres, MD |
17:20 – 18:05 | Waldenstom’s Macroglobulinemia and Amyloidosis | Morie A. Gertz, MD |
18:05 – 18:10 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
18:10 – 19:30 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Sunday, August 15, 202Day 1: Hematologic Malignancies Session
Monday, August 16, 2021- Day 2: Hematologic Malignancies Session | ||
Time | Topic | Presenter |
06:45 – 07:45 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
07:45 – 07:50 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
07:50 – 08:50 | Acute Myeloid Leukemia | Richard Stone, MD |
08:50 – 10:05 | Bone Marrow Transplantation | F Marc Stewart, MD |
10:05 – 10:25 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:25 – 11:25 | Myeloproliferative Neoplasms | Ayalew Tefferi, MD |
11:25 – 12:25 | Pharmacology I | Edward Chu, MD |
12:25 – 12:55 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
12:55 – 14:40 | Lunch Review Session 5: | Moderator: Dr. R. Siegel |
14:40 – 15:25 | Pharmacology II | Edward Chu, MD |
15:25 – 16:10 | Pharmacology III | Edward Chu, MD |
16:10 – 16:30 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
16:30 – 17:15 | Palliative Care | Erica Schockett, MD |
17:15 – 18:00 | Next Gen Sequencing for the Diagnosis and Treatment of Neoplastic Disorders | Skip Burris, MD |
18:00 – 18:45 | T Cell Therapies for Cancer | Catherine Bollard, MD |
18:45 – 19:30 | Hematologic Complications of COVID | (Faculty: tbc) |
19:30 – 19:40 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
19:40 – 20:30 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Tuesday, August 17, 2021- Day 1: Oncology Session | ||
Time | Topic | Presenter |
06:45 – 07:45 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
07:45 – 07:55 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
07:55 – 08:55 | Familial Cancer Syndromes | Elizabeth Stark, MS, CGC |
08:55 – 09:55 | (Topic: tbc) | (Faculty: tbc) |
09:55 – 10:50 | Non-Small Cell Lung Cancer | Bruce E. Johnson |
10:50– 11:10 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
11:10 – 11:55 | Small Cell Lung Cancer | Bruce E. Johnson, MD |
11:55 – 12:40 | Adjuvant Therapy For Breast Cancer | Nancy Davidson, MD |
12:40 – 13:10 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
13:10 – 14:45 | Lunch Review Session 6: | Moderator: Dr. R. Siegel |
14:45 – 15:30 | Metastatic Breast Cancer | Claudine Isaacs, MD |
15:30 – 15:50 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
15:50 – 16:35 | Neuro-Oncology | Mark Gilbert, MD |
16:35 – 17:20 | Metastatic Disease to the Brain, Spine, Carcinomatous Meningitis | Mark Gilbert, MD |
17:20 – 18:05 | Endocrine Malignancies | Anne Gramza, MD |
18:05 – 18:15 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
18:15 – 19:30 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Wednesday, August 18, 2021- Day 2: Oncology Session | ||
Time | Topic | Presenter |
07:00 – 08:00 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
08:00 – 08:10 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:10 – 08:55 | Renal Cell Cancer | Dean F. Bajorin, MD |
08:55 – 09:55 | Prostate Cancer | Jeanny B. Aragon-Ching, MD |
09:55– 10:15 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:15 – 11:00 | Bladder Cancer | Dean F. Bajorin, MD |
11:00 – 11:45 | Testicular Cancer and Mediastinal Germ Cell Tumors | Darren Feldman, MD |
11:45 – 12:45 | Ovarian Cancer | Andrea Wahner-Hendrickson, MD |
12:45 – 13:15 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
13:15 – 14:45 | Lunch Review Session 7: | Moderator: Dr. R. Siegel |
14:45 – 15:15 | Endometrial Cancer | Andrea Wahner-Hendrickson, MD |
15:15 – 16:15 | Cancer of the Cervix, Vulva, Vagina and Gestational Trophoblastic Tumors | Daniel L. Clarke-Pearson, MD |
16:15 – 16:35 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
16:35 – 17:20 | Pancreatic Cancer | Hedy Lee Kindler, MD |
17:20 – 18:05 | Mesothelioma | Hedy Lee Kindler, MD |
18:05 – 18:50 | Melanoma | F. Stephen Hodi, MD |
18:50 – 19:00 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
19:00 – 20:00 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Thursday, August 19, 2021- Day 3: Oncology Session | ||
Time | Topic | Presenter |
06:30 – 07:30 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
07:30 – 07:40 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
07:40 – 08:25 | Carcinoid Tumors, Carcinoid Syndrome and Pancreatic Neuroendocrine Tumors | Diane Reidy-Lagunes, MD |
08:25 – 09:10 | Esophageal Carcinoma | David Ilson, MD |
09:10 – 09:55 | Gastric Cancer | David Ilson, MD |
09:55– 10:15 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:15 – 11:00 | (Topic: tbc) | (Faculty: tbc) |
11:00 – 12:00 | Adjuvant Therapy for Colon and Rectal Cancer | Daniel G. Haller, MD |
12:00 – 12:45 | Anal Cancer | Daniel G. Haller, MD |
12:45 – 13:15 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
13:15 – 14:05 | Lunch Review Session 8: | Moderator: Dr. R. Siegel |
14:05 – 14:50 | Hepatobiliary Cancer | Daniel G. Haller, MD |
14:50 – 15:35 | Sarcomas | Mark Agulnik, MD |
15:35 – 15:45 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
15:45 – 17:00 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Course Agenda
Course Director: Robert S. Siegel, MD
Tentative Agenda is subject to change. All times listed in Eastern Daylight Time (EDT).
** Please visit our Sponsor Exhibitors during breaks, if you have not scheduled an appointment in advance. **
Friday, August 20, 2021- Supplemental Lectures Session | ||
Time | Topic | Presenter |
07:00 – 08:00 | Breakfast | Visit MYHEMONC Hub | Exhibitors | All Attendees |
08:00 – 08:10 | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:10 – 09:10 | Updates in Breast Cancer (live Q&A) | (Faculty: tbc) |
09:10 – 10:10 | Updates in Lung Cancer (live Q&A) | Benjamin Levy, MD |
10:10 – 10:30 | Break | Visit MYHEMONC Hub | Exhibitors | All Attendees |
10:30 – 11:15 | (Topic: tbc) | (Faculty: tbc) |
11:15 – 12:00 | Updates in Urologic Cancer | Jeanny Aragon-Ching, MD |
12:00 – 12:45 | New Advances in Pharmacology | Edward Chu, MD |
12:45 – 13:45 | Lunch Panel Discussion | Moderator: Dr. R. Siegel |
13:45 – 14:15 | Lunch | Visit MYHEMONC Hub | Exhibitors | All Attendees |
14:15 – 15:00 | Telemedicine | Susan Dentzer |
15:00 – 15:45 | (Topic: tbc) | (Faculty: tbc) |
15:45 – 16:30 | (Topic: tbc) | (Faculty: tbc) |
16:30 – 15:15 | COVID 19 and Cancer Therapy | Henry Masur, MD |
17:15 – 17:25 | Closing Remarks | Adjournment | Robert S. Siegel, MD |
17:25 – 18:30 | Visit MYHEMONC Hub | Exhibitors | All Attendees |
Physicians
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 79.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists
Available Credit
- 79.25 ABIM MOC 2
- 70.00 ACPE PharmacistThe George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 79.25 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 79.25 Completion
SPONSORSHIP
HEMONC Best Practices is a great opportunity for your company to display your products and services and to interact with our audience of 400+ physicians, nurses and allied healthcare professionals.
Why Exhibit
Our Sponsor Exhibitors will have the opportunity to:
- Demonstrate your company’s commitment to improving the care of patients with blood disorders and cancerous tumors
- Benefit from extended Exhibit Hours throughout the conference days, giving you maximum visibility
- Educate physicians and other healthcare professionals about your company’s products and service
- Reach decision makers in the Hematology and Oncology market
- Increase your Team and Company’s visibility
MYHEMONC EXHIBIT HUB
Our MYHEMONC Exhibit Hub will offer our Exhibitors the following benefits:
- Maximum visibility and exposure to your target market
- Complimentary Virtual Educational Sessions & Exhibit Hub Access for (2) two Company Personnel
- Our Virtual Exhibit Raffle drives attendees to your booth in the Exhibit Hub. When attendees participate in the Exhibit Hub gamification activities, attendees will be eligible for special prize drawings
- Automatic inclusion in the Exhibit Hub raffle (prizes selected and distributed by Course Director)
- Acknowledgment in Online Course Materials (subject to set course material deadlines)
- Acknowledgement in Educational Sessions
Sponsor Exhibitor Tuition Fees
Please refer to the “Registration and Fees” tab for Industry rates.
Sponsor Exhibitor Schedule
Please Note: Refer to the program tab for agenda details.
Exhibitor Prospectus
If you are interested in exhibiting at our MYHEMONC Exhibit Hub during our live sessions, please download the 2021 HEMONC Best Practices Exhibitor Sponsor Prospectus for more information.
Price
REGISTRATION FEES
When you register for the HEMONC Best Practices course, the registration fee includes:
- Access to the Virtual Educational Sessions and LIVE Board Review Sessions with Audience Polling and Q&A
- Access to the MYHEMONC Exhibit Hub and connect with our Sponsor Exhibitors
- Access Online to the Course Materials
- Access to Archived Session Recordings for 1 Year
- CME Credit and MOC Points
Home study customers- complimentary access to virtual exhibit hub
- If you have purchase the HEMONC Best Practices Home Study Course this year, you have complimentary access to the MYHEMONC Virtual Exhibit Hub
special discounted rates
- By visiting our site, please apply promotional code HEMONCFLASH for a 10% discounted rate. (This promotional code is valid until August 4, 2021)
purchase disclaimer
- Please note that the Ethos CE system is designed to track individual learning. The learning system does not permit shared logins; any attempt of this activity will be monitored and your subscription will be at risk to be suspended at GW's discretion
hemonc BEST PRACTICES | Early | Late | Group | Group |
Physicians | $1,825.00 | $2,000.00 | $4,000.00 | $6,400.00 |
Residents | Fellows | $1,000.00 | $1,600.00 | $3,000.00 | $5,400.00 |
Nurses | Pharmacists | APN | APA | Advanced Practice Providers | Allied Professionals and Other Healthcare Providers | $700.00 | $950.00 | $1,600.00 | $2,750.00 |
Industry | $2,350.00 | $2,550.00 | N/A | N/A |
HEmATOLOGY best practices | Early | Late | Group | Group |
Physicians | $1,100.00 | $1,300.00 | $2,375.00 | $3,500.00 |
Residents | Fellows | $850.00 | $1,000.00 | $1,875.00 | $2,750.00 |
Nurses | Pharmacists | APN | APA | Advanced Practice Providers | Allied Professionals and Other Healthcare Providers | $425.00 | $525.00 | $875.00 | $1,250.00 |
Industry | $1,525.00 | $1,800.00 | N/A | N/A |
ONCOLOGY best practices | Early | Late | Group | Group |
Physicians | $1,100.00 | $1,300.00 | $2,375.00 | $3,500.00 |
Residents | Fellows | $850.00 | $1,000.00 | $1,875.00 | $2,750.00 |
Nurses | Pharmacists | APN | APA | Advanced Practice Providers | Allied Professionals and Other Healthcare Providers | $425.00 | $525.00 | $875.00 | $1,250.00 |
Industry | $1,525.00 | $1,800.00 | N/A | N/A |
ONCOLOGY UPDATE | Early | Late |
Physicians | $225.00 | $250.00 |
Residents | Fellows | $150.00 | $200.00 |
Nurses | Pharmacists | APN | APA | Advanced Practice Providers | | $75.00 | $100.00 |
For group registrations over 5 participants, please click here.